|
Volumn 41, Issue 1, 2001, Pages 35-43
|
Single-dose pharmacokinetics of sotalol in a pediatric population with supraventricular and/or ventricular tachyarrhythmia
a b c d a e e e e e |
Author keywords
[No Author keywords available]
|
Indexed keywords
CREATININE;
SOTALOL;
ARTICLE;
BETA ADRENERGIC RECEPTOR BLOCKING;
BODY SIZE;
BODY SURFACE;
BODY WEIGHT;
CHILD;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CREATININE CLEARANCE;
DRUG ABSORPTION;
DRUG BLOOD LEVEL;
DRUG CLEARANCE;
DRUG DISTRIBUTION;
DRUG ELIMINATION;
DRUG HALF LIFE;
DRUG TOLERABILITY;
FEMALE;
HEART VENTRICLE TACHYCARDIA;
HUMAN;
INFANT;
MALE;
NEWBORN;
QT INTERVAL;
SUPRAVENTRICULAR TACHYCARDIA;
ADRENERGIC BETA-ANTAGONISTS;
AGING;
ANTI-ARRHYTHMIA AGENTS;
CHILD;
CHILD, PRESCHOOL;
DRUG ADMINISTRATION SCHEDULE;
DRUG INTERACTIONS;
FEMALE;
HUMANS;
INFANT;
INFANT, NEWBORN;
LINEAR MODELS;
MALE;
SOTALOL;
TACHYCARDIA, SUPRAVENTRICULAR;
TACHYCARDIA, VENTRICULAR;
|
EID: 0034749480
PISSN: 00912700
EISSN: None
Source Type: Journal
DOI: 10.1177/00912700122009818 Document Type: Article |
Times cited : (19)
|
References (24)
|